ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Big pharma mergers unlikely in near future: Dr Reddy's MD GV Prasad
Large mergers and acquisitions in the Indian pharmaceutical market are unlikely soon due to various uncertainties, says GV Prasad of Dr Reddy's Laboratories. The company is focusing on diversifying its portfolio, investing in R&D for the branded generi
Announcement as on 16 March 2025

Senores Pharma to acquire 14 ANDAs from Dr Reddy's Laboratories
Senores Pharmaceuticals of Gujarat has signed an agreement to acquire 14 Abbreviated New Drug Applications from Dr Reddy's Laboratories. The acquisition, funded through IPO proceeds, includes 13 USFDA-approved ANDAs. This expands Senores' product offerings
Announcement as on 04 March 2025

Indian drugmakers likely to stay competitive despite planned tariffs, Dr Reddy's says
Indian drugmakers, including Dr Reddy's, are confident about maintaining competitiveness in the generic drugs market despite potential U.S. tariffs on pharmaceutical imports. Dr Reddy's MD, GV Prasad, stated that Indian firms are awaiting more details on t
Announcement as on 25 February 2025

Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories showcases stability with low beta

Announcement as on 14 February 2025

Dr Reddy's unit ties up with Shanghai Henlius Biotech
Dr Reddy's Laboratories has partnered with Shanghai Henlius Biotech to develop and commercialize HLX15, a biosimilar to the cancer drug Darzalex. Henlius will manage development and manufacturing, receiving up to 1.6 million. Dr Reddy's gains exclusive
Announcement as on 06 February 2025

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 13.52
  • 12Day Average: 13.7
  • 20Day Average: 13.95
  • 50Day Average: 14.04
  • 100Day Average: 13.93
  • 150Day Average: 14.04
  • 200Day Average: 14.16

RDY Indicators & signals

Indicator MACD (12,26,9)

13.7, 13.89, -0.13
Indicator MACD is in negative zone

Indicator ADX (14)

26.32, 21.88, 37.5
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 50
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Thu Apr 2026 13.32 13.03 to 13.36 -1.11% 1.87 times
01 Wed Apr 2026 13.47 13.43 to 13.66 -2.74% 1.28 times
31 Tue Mar 2026 13.85 13.62 to 13.91 2.9% 0.85 times
30 Mon Mar 2026 13.46 13.37 to 13.59 -0.15% 0.75 times
27 Fri Mar 2026 13.48 13.47 to 13.66 -2.11% 0.61 times
26 Thu Mar 2026 13.77 13.76 to 13.95 -0.72% 0.85 times
25 Wed Mar 2026 13.87 13.79 to 13.97 3.12% 0.79 times
24 Tue Mar 2026 13.45 13.40 to 13.67 -1.75% 1.1 times
23 Mon Mar 2026 13.69 13.60 to 13.86 -0.44% 1.69 times
20 Fri Mar 2026 13.75 13.75 to 14.20 -2.83% 1.24 times
19 Thu Mar 2026 14.15 13.94 to 14.31 -0.28% 0.84 times
17 Tue Mar 2026 14.19 14.06 to 14.29 1% 0.67 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

 

Back to top